---
title: "Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/289629769.md"
description: "In Boston, Massachusetts, on June 1, 2026, Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company focused on revolutionizing autoimmune disease treatment, revealed that the Compensation Committee of the Board of Directors issued stock options for 61,050 shares of Vor Bio’s common stock and restricted stock units (RSUs) for 12,900 shares of Vor Bio’s common stock to 10 newly onboarded employees. These incentives were provided under the Nasdaq Listing Rule 5635(c)(4) and granted via the Vor Biopharma Inc. 2023 Inducement Plan as enticements for joining the company."
datetime: "2026-06-12T18:10:20.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/289629769.md)
  - [en](https://longbridge.com/en/news/289629769.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/289629769.md)
---

# Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

In Boston, Massachusetts, on June 1, 2026, Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company focused on revolutionizing autoimmune disease treatment, revealed that the Compensation Committee of the Board of Directors issued stock options for 61,050 shares of Vor Bio’s common stock and restricted stock units (RSUs) for 12,900 shares of Vor Bio’s common stock to 10 newly onboarded employees. These incentives were provided under the Nasdaq Listing Rule 5635(c)(4) and granted via the Vor Biopharma Inc. 2023 Inducement Plan as enticements for joining the company.

### Related Stocks

- [VOR.US](https://longbridge.com/en/quote/VOR.US.md)

## Related News & Research

- [RA Capital Healthcare Fund disposes of 213 Vor Biopharma shares worth $4,206.75](https://longbridge.com/en/news/293385729.md)
- [Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | VOR Stock News](https://longbridge.com/en/news/291592393.md)
- [Vor Bio grants inducement awards to new hires, including options for 71,200 shares at $18.39](https://longbridge.com/en/news/291592170.md)
- [Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | VOR Stock News](https://longbridge.com/en/news/288330248.md)
- [Vor Biopharma Inc. (NASDAQ:VOR) Given Average Recommendation of "Moderate Buy" by Analysts](https://longbridge.com/en/news/292722662.md)